期刊文献+

激素联合雷公藤治疗抗PLA2R抗体阳性中老年IMN疗效 被引量:1

Effect of Hormone Combined with Tripterygium Wilfordii on Anti-PLA2R Positive Middle-aged IMN
下载PDF
导出
摘要 目的:探讨激素联合雷公藤治疗抗PLA2R抗体阳性中老年特发性膜性肾病(IMN)效果及对抗PLA2R抗体滴度的影响。方法:选取2019年1月~2021年6月我院收治的26例IMN的45岁以上的中老年患者,且检测血清抗PLA2R抗体阳性。依照随机数字表法将其分为观察组(13例)与对照组(13例),分别于入院时、用药12周、用药24周完善化验与检查,并对相关数据进行统计与分析。结果:用药12周时,两组患者间生化指标、临床完全缓解率均无统计学差异(P>0.05)。用药24周时,观察组的血浆白蛋白水平高于对照组,差异均有统计学意义(P<0.05);24小时尿蛋白定量、血清抗PLA2R抗体浓度均低于对照组,差异同样具有统计学意义(P<0.05);临床完全缓解率高于对照组,差异同样具有统计学意义(P<0.05)。结论:激素联合雷公藤多甙对血清抗PLA2R抗体阳性的中老年IMN安全且有效,能有效增加患者临床缓解率。 Objective:To investigate the effect of hormone combined with Tripterygium Wilfordii on the treatment of middle-aged idiopathic membranous nephropathy(IMN)with anti-PLA2R positive.Methods:Atotalof26 patients over 45 years old with IMN treated in our hospital from January 2019 to June 2021 were selectedandrandomly divided into observation group(13 cases)and control group(13 cases).Their serum anti-PLA2R was positive.The tests and examinations were completed at admission,12 weeks and 24 weeks.The relevant data were counted and analyzed.Results:After 12 weeks treatment,there was no significant difference in biochemical indexes and clinical complete remission rate between the two groups(P>0.05).However,after 24 weeks treatment,the plasma albumin level in the observation group was higher than that in the control group(P<0.05),while 24-hour urinary protein and serum anti-PLA2R concentration were lower than those in the control group(P<0.05).The clinical complete remission rate was higher than that in the control group with statistically significant(P<0.05).Conclusion:Hormone combined with Tripterygium wilfordii is safe and effective for middle-aged IMN with serum anti-PLA2R positive.It could effectively increase the clinical remission rate of patients.
作者 谢敏娟 徐石张 XIE Min-juan;XU Shi-zhang(Medical College of Yichun University,Yichun 336000,China;Department of Nephrology,The People’s Hospital of Yichun City,Yichun 336000,China)
出处 《宜春学院学报》 2021年第12期26-29,共4页 Journal of Yichun University
基金 江西省卫生健康委员会科技计划项目(编号:20204732)。
关键词 激素 雷公藤 抗PLA2R抗体 中老年 IMN 疗效 hormones Tripterygium wilfordii anti-PLA2R middle aged IMN curative effect
  • 相关文献

参考文献3

二级参考文献12

  • 1梅长林.对特发性膜性肾病治疗的评价[J].中华肾脏病杂志,2004,20(5):309-310. 被引量:11
  • 2Glassock RJ. Diagnosis and natural course of membranous nephr opathy[J].Seminars in Nephrology,2003,(04):324-332. 被引量:1
  • 3Perna A,Schieppati A,Zamora J. Immunosuppressive treatment for idiopathic membranous nephropathy:a systematic review[J].American Journal of Kidney Diseases,2004,(03):385-401. 被引量:1
  • 4Jha V,Ganguli A,Saha TK. A randomized,controlled trial of steroids and cycloph os phamide in adults with nephritic syndrome caused by idiopathic mem branous nephropathy[J].Journal of the American Society of Nephrology,2007,(06):1899-1904.doi:10.1681/ASN.2007020166. 被引量:1
  • 5Waldman M,Austin HA 3rd. Cont roversies in the treatm ent of idiopathic membranous nephropathy[J].Nat Rev Nephrol,2009,(08):469-479.doi:10.1038/nrneph.2009.101. 被引量:1
  • 6Goumenos DS,Katopodis KP,Passadakis P. Corticosteroids and ciclosporin A in idiopathic membranous nephropathy:higher remission rates of nephrotic syndrome and less adverse reactions than after traditional treatment with cytotoxic drugs[J].American Journal of Nephrology,2007,(03):226-231.doi:10.1159/000101367. 被引量:1
  • 7Praga M,Barrio V,Jurez GF. Tacrolimusm ono therapy in membranous nephropathy:a randomized controlled trial[J].Kidney International,2007,(09):924-930.doi:10.1038/sj.ki.5002215. 被引量:1
  • 8Chan TM,Lin AW,Tang SC. Prospective controlled study on mycophenolate mofetil and prednisol one in the treatment of membranous nephropathy with nephroticsynd rome[J].Nephrology,2007,(06):576-581. 被引量:1
  • 9Dussol B,Morange S,Burtey S. Mycophenolate mofet ilmonotherapy in membranous neph ropathy:a1 year randomized controlled trial[J].American Journal of Kidney Diseases,2008,(04):699-705.doi:10.1053/j.ajkd.2008.04.013. 被引量:1
  • 10Branten AJ,du Buf? Vereijken PW,Vervloet M. Mycop henolate mofetil in idiopathic membran ous nephropathy:a clinical trial with comparison to ahistoric controlgrouptreat ed with cycloph osphamide[J].American Journal of Kidney Diseases,2007,(02):248-256. 被引量:1

共引文献92

同被引文献13

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部